Benzimidazole Heterocycle as a Privileged Scaffold in Antiviral Agents

E-ISSN： 1875-6298|9|4|397-410

ISSN： 1570-193X

Source： Mini-Reviews in Organic Chemistry, Vol.9, Iss.4, 2012-11, pp. : 397-410

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Coumarin: A Natural, Privileged and Versatile Scaffold for Bioactive Compounds

By Stefanachi Angela Leonetti Francesco Pisani Leonardo Catto Marco Carotti Angelo

Molecules, Vol. 23, Iss. 2, 2018-01 ,pp. : 250-250

MDPI

Access to resources Recommend Favorite

Synthetic Strategies Applicable in the Synthesis of Privileged Scaffold: 1,4-Benzodiazepine

By Kaur Navjeet Kishore Dharma

Synthetic Communications, Vol. 44, Iss. 10, 2014-05 ,pp. : 1375-1413

Taylor & Francis Ltd

Access to resources Recommend Favorite

Cobalt Complexes as Antiviral and Antibacterial Agents

By Chang Eddie L. Simmers Christa Knight D. Andrew

Pharmaceuticals, Vol. 3, Iss. 6, 2010-05 ,pp. : 1711-1728

MDPI

Access to resources Recommend Favorite

Nucleophilic ligand displacement in dichloro[2-(arylazo)heterocycle]palladium(II) complexes by benzimidazole – a kinetic and mechanistic study

By Roy R.

Transition Metal Chemistry, Vol. 26, Iss. 1-2, 2001-02 ,pp. : 205-211

Springer Publishing Company

Access to resources Recommend Favorite

Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site

By Dong Mengqi Liu Fang Zhou Hongyu Zhai Shumei Yan Bing

Molecules, Vol. 21, Iss. 10, 2016-10 ,pp. : 1375-1375

MDPI

Access to resources Recommend Favorite